UY27030A1 - HEPATITIS C VIRUS INHIBITORS - Google Patents

HEPATITIS C VIRUS INHIBITORS

Info

Publication number
UY27030A1
UY27030A1 UY27030A UY27030A UY27030A1 UY 27030 A1 UY27030 A1 UY 27030A1 UY 27030 A UY27030 A UY 27030A UY 27030 A UY27030 A UY 27030A UY 27030 A1 UY27030 A1 UY 27030A1
Authority
UY
Uruguay
Prior art keywords
hepatitis
analogs
virus inhibitors
treatment
methods
Prior art date
Application number
UY27030A
Other languages
Spanish (es)
Inventor
Jeffrey Allen Campbell
Andrew Good
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to UY27030A priority Critical patent/UY27030A1/en
Publication of UY27030A1 publication Critical patent/UY27030A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a compuestos tripeptidicos, composiciones y métodos para el tratamiento de la infección por virus de hepatitis C (HCV). En particular, la presente invención proporciona análogos tripeptídicos novedosos, composiciones farmacéuticas que contienen tales análogos y métodos para utilizar estos análogos en el tratamiento de infección por HCV.The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.

UY27030A 2001-11-20 2001-11-20 HEPATITIS C VIRUS INHIBITORS UY27030A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27030A UY27030A1 (en) 2001-11-20 2001-11-20 HEPATITIS C VIRUS INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27030A UY27030A1 (en) 2001-11-20 2001-11-20 HEPATITIS C VIRUS INHIBITORS

Publications (1)

Publication Number Publication Date
UY27030A1 true UY27030A1 (en) 2002-07-31

Family

ID=38812533

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27030A UY27030A1 (en) 2001-11-20 2001-11-20 HEPATITIS C VIRUS INHIBITORS

Country Status (1)

Country Link
UY (1) UY27030A1 (en)

Similar Documents

Publication Publication Date Title
ATE503764T1 (en) HEPATITIS C VIRUS INHIBITORS
ATE327246T1 (en) HEPATITIS C TRIPEPTIDE INHIBITORS
DE60334205D1 (en) Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
ATE413411T1 (en) SUBSTITUTED CYCLOALKYL P1' HEPATITIS C VIRUS INHIBITORS
CL2004001161A1 (en) COMPOUNDS DESCRIBES COMPOUNDS DERIVED FROM QUINOLINA; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT AN ILLNESS CAUSED BY THE HEPATITIS C VIRUS.
BR0305426A (en) Hsv ns5b polymerase inhibitor compounds as well as pharmaceutical composition comprising the same
BR112012011100A2 (en) hepatitis virus inhibitor compounds, composition and use thereof
BRPI0716483B8 (en) hepatitis c virus inhibitor compounds and pharmaceutical composition comprising them
BR0305259A (en) Hcv ns5b polymerase inhibitors
EA200900297A1 (en) HEPATITIS C VIRUS INHIBITORS
ATE551337T1 (en) HEPATITIS C VIRUS INHIBITORS
ATE512976T1 (en) HEPATITIS C VIRUS INHIBITORS
EA200800178A1 (en) HEPATITIS C VIRUS INHIBITORS (HCV)
WO2010034105A8 (en) Hepatitis c inhibitor compounds
BR112013020042A2 (en) hepatitis c virus inhibitors
UY27030A1 (en) HEPATITIS C VIRUS INHIBITORS
ECSP003414A (en) ACTIVE MACROCICLIC PEPTIDES AGAINST HEPATITIS C VIRUS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141105